Robert Zeiser

University of Freiburg — Germany

Medicine · Health Sciences

77h-index24.6kcitations616works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(220), Immune Cell Function and Interaction(157), Acute Myeloid Leukemia Research(91), T-cell and B-cell Immunology(82), CAR-T cell therapy research(68)

Publications612 total

Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies
Signal Transduction and Targeted Therapy·2025Open Access
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT
Bone Marrow Transplantation·2025Open Access
Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee
Bone Marrow Transplantation·2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice
Science Translational Medicine·2025
Identifying Biomedical Entities for Datasets in Scientific Articles: 4-Step Cache-Augmented Generation Approach Using GPT-4o and PubTator 3.0
JMIR Formative Research·2025· 3 citedOpen Access
<scp>DNA</scp> methyltransferase inhibitors in hematological malignancies and solid tumors
International Journal of Cancer·2025· 2 citedOpen Access
Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD
Blood·2025Open Access
Autologous, allogeneic haemopoietic stem cell transplantation and CART cell therapy for tranformed Waldenström's macroglobulinemia to high grade non-Hodgkin lymphoma. real world outcomes report from the lymphoma working party of the european society for blood and marrow transplantation (LWP EBMT)
Blood·2025Open Access
Axatilimab in combination with ruxolitinib in patients with newly diagnosed chronic graft-versus-host disease: Interim safety analysis of a phase 2, randomized study
Blood·2025Open Access
Relapse with post-transplant tyrosine kinase inhibitor (TKI) maintenance therapy in phliladelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) after allogeneic hematopoietic stem cell transplantation: Incidence and risk factor analysis
Blood·2025
Enteral supplementation with a TGF-β-enriched polymeric diet mitigates gastrointestinal acute gvhd
Blood·2025Open Access
Anti-inflammatory drug pegtarazimod (RLS-0071) demonstrates clinical improvement in lower gastrointestinal acute graft-versus-host disease (aGvHD) and target engagement of key inflammatory marker myeloperoxidase (MPO)
Blood·2025Open Access
Menin-inhibition boosts CAR-T cell therapy against NPM1 mutated and KMT2A-rearranged acute myeloid leukemia
Blood·2025
Post allo-HCT menin-inhibition enhances graft-versus-leukemia effects by endogenous retrovirus induction in AML and T-cell activation
Blood·2025
Long-term outcomes of syngeneic transplantation in multiple myeloma: Valuable legacy or obsolete option? a study from the chronic malignancies working party of the EBMT
Blood·2025Open Access
Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT
Blood·2025
NLRP6 regulates ZAP-70-erk signaling in both murine and human T cells and influences acute graft-versus-host disease(GVHD)
Blood·2025Open Access
Gastrin for the treatment of acute graft-versus-host disease of the stomach
Blood·2025
Impact of NRAS and/or KRAS mutations on post-transplant outcomes in Acute Myeloid Leukemia: A study on behalf of EBMT-ALWP
Blood·2025
3005 – DIFFERENTIATION, AGING, AND LEUKEMIA ALTER THE METABOLIC PROFILE OF HUMAN BONE MARROW HEMATOPOIETIC STEM AND PROGENITOR CELLS
Experimental Hematology·2025
page 1 of 31Next →

Frequent Co-authors

Bruce R. Blazar(13), Jürgen Finke(10), Annette Schmitt‐Graeff(10), Justus Duyster(10), Dietmar Pfeifer(7), Robert S. Negrin(6), Andreas Beilhack(6), Marco Idzko(6), Tilman Brummer(6), Nikolas von Bubnoff(5), Nicolaus Kröger(5), Petya Apostolova(5), Tobias Müller(5), Franziska Maria Uhl(5), Jakob Passweg(4), Stephan Sorichter(4), Davide Ferrari(4), Stefan F. Martin(4), Melanie Boerries(4), Natalie Stickel(4)